{"id":"https://openalex.org/W1905409013","doi":null,"title":"Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer.","display_name":"Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer.","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W1905409013","mag":"1905409013","pmid":"https://pubmed.ncbi.nlm.nih.gov/20651377"},"language":"en","primary_location":{"id":"pmid:20651377","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20651377","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase I"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113478579","display_name":"Antonio Ant\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Anton","raw_affiliation_strings":["Medical Oncology Service, University Hospital Miguel Servet, Avda. Isabel La Cat\u00f3lica 1-3, 50009 Zaragoza, Spain. aantont@salud.aragon.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Service, University Hospital Miguel Servet, Avda. Isabel La Cat\u00f3lica 1-3, 50009 Zaragoza, Spain. aantont@salud.aragon.es","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026179323","display_name":"Ana M. Lluch","orcid":"https://orcid.org/0000-0003-2766-407X","observed_orcids":["https://orcid.org/0000-0003-2766-407X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Lluch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049908989","display_name":"Antonio Casado","orcid":"https://orcid.org/0000-0002-8200-3306","observed_orcids":["https://orcid.org/0000-0002-8200-3306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Casado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085499011","display_name":"Mariano Provencio","orcid":"https://orcid.org/0000-0001-9053-9197","observed_orcids":["https://orcid.org/0000-0001-9053-9197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariano Provencio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089285482","display_name":"Montserrat Mu\u00f1oz-Mateu","orcid":"https://orcid.org/0000-0001-7772-1437","observed_orcids":["https://orcid.org/0000-0001-7772-1437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Montserrat Mu\u00f1oz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103481471","display_name":"Juan Lao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Lao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018922989","display_name":"Bego\u00f1a Bermejo","orcid":"https://orcid.org/0000-0001-7773-5994","observed_orcids":["https://orcid.org/0000-0001-7773-5994"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bego\u00f1a Bermejo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016491384","display_name":"Ana Bel\u00e9n Paules","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana B Paules","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071407718","display_name":"Javier Gayo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Gayo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100671433","display_name":"Miguel Mart\u00edn","orcid":"https://orcid.org/0000-0001-9237-3231","observed_orcids":["https://orcid.org/0000-0001-9237-3231"]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Martin","raw_affiliation_strings":["Hospital Miguel Servet"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Miguel Servet","institution_ids":["https://openalex.org/I4210114530"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3248,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.62220276,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"30","issue":"6","first_page":"2255","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8389999866485596},{"id":"https://openalex.org/keywords/oral-vinorelbine","display_name":"oral vinorelbine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/recommended-dose","display_name":"recommended dose","score":0.5799999833106995},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9639999866485596},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.574999988079071},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9151304960250854},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.8907144069671631},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.866969108581543},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7881549596786499},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6940149068832397},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5716720223426819},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5618647336959839},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5572303533554077},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5449627041816711},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5091583132743835},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4884397089481354},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.48352789878845215},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4305635094642639},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.36836135387420654},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36452656984329224},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.18219736218452454},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1327616572380066},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:20651377","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20651377","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase I"},{"id":"mag:1905409013","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20651377","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1976067234","https://openalex.org/W2135378470","https://openalex.org/W2115931762","https://openalex.org/W7099775130","https://openalex.org/W2106804959","https://openalex.org/W2063775957","https://openalex.org/W2048532113","https://openalex.org/W2028697269","https://openalex.org/W2243659306","https://openalex.org/W2125930061"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"determine":[2,80],"the":[3,81,85,151],"recommended":[4,82,156],"doses":[5,83],"of":[6,46,87,119,161,172],"oral":[7,27,88,162],"vinorelbine":[8],"(VN)":[9],"and":[10,32,34,53,59,65,71,90,104,121,124,167,169],"capecitabine":[11],"(C)":[12],"in":[13,92,117,128,150,179],"metastatic":[14,23,93],"breast":[15,24,94],"cancer.":[16,95],"PATIENTS":[17],"AND":[18],"METHODS:":[19],"Eighteen":[20],"patients":[21],"with":[22,187],"cancer":[25],"received":[26],"VN":[28,89,108,163],"(on":[29,36],"days":[30,37,165,175],"1":[31,38,166,176],"8)":[33],"C":[35,91,173],"to":[39,79,177],"14)":[40],"every":[41],"three":[42,180],"weeks":[43],"at":[44],"one":[45,129],"four":[47],"dose":[48,157],"levels:":[49],"I)":[50],"60":[51],"mg/m(2)":[52,58,64,70,160],"1650":[54,60],"mg/m(2)/day;":[55,61,67],"II)":[56],"70":[57,63],"III)":[62],"2000":[66,72,170],"IV)":[68],"80":[69,159],"mg/m(2)/day,":[73],"respectively.":[74],"The":[75,142,155],"primary":[76],"endpoint":[77],"was":[78,111,145],"for":[84],"combination":[86],"Secondary":[96],"endpoints":[97],"include":[98],"evaluating":[99],"response":[100,143],"rate,":[101],"safety":[102],"profile":[103],"whether":[105],"or":[106],"not":[107],"dosage":[109],"escalation":[110],"required.":[112],"RESULTS:":[113],"Severe":[114],"neutropenia":[115],"occurred":[116],"28%":[118,146],"patients;":[120],"severe":[122],"anaemia":[123],"leucopenia":[125],"were":[126,140],"observed":[127],"patient":[130,134],"each":[131],"(6%).":[132],"One":[133],"developed":[135],"febrile":[136],"neutropenia.":[137],"Non-hematological":[138],"toxicities":[139],"rare.":[141],"rate":[144],"(95%":[147],"CI:":[148],"10-54)":[149],"intention-to-treat":[152],"population.":[153],"CONCLUSION:":[154],"is":[158,190],"on":[164],"8,":[168],"mg/m(2)/day":[171],"from":[174],"14":[178],"weekly":[181],"cycles.":[182],"A":[183],"phase":[184],"II":[185],"study":[186],"this":[188],"schedule":[189],"currently":[191],"under":[192],"way.":[193]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}